SCHEMBL4479336

SCHEMBL4479336

CC1C=CC=CC1([N+](=O)[O-])S(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8651938 0.83
SCHEMBL28836250 0.83
SCHEMBL11827681 0.80
SCHEMBL4215116 0.71
SCHEMBL6624705 0.71
SCHEMBL18301365 0.69
SCHEMBL4445312 0.68
SCHEMBL6106125 0.68
SCHEMBL1592496 0.67
SCHEMBL9779302 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625917-B2 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein TURPIN JAMES A 2009-12-01 US disclosed
EP-1087941-B9 THIOLESTERS AND USES THEREOF US HEALTH (US) 2007-11-07 EP disclosed
US-7101875-B2 Methods for treating arthritic disorders WYETH (US) 2006-09-05 US disclosed
EP-1087941-B1 THIOLESTERS AND USES THEREOF US HEALTH (US) 2006-08-16 EP disclosed
EP-1501826-A2 SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS F. Hoffman-la Roche AG (CH) 2005-02-02 EP disclosed
US-6797708-B2 ENZYME INHIBITORS SUCH AS 4-(2-(1-BENZHYDRYL-2-(2-((BENZYL-SULFONYL)AMINO)ETHYL)-5-CHLORO-1H-INDOL-3 -YL)ETHOXY) BENZOIC ACID, USED AS ANALGESICS OR ANTIINFLAMMATORY AGENTS WYETH 2004-09-28 US disclosed
US-20040132785-A1 Thiolesters and uses thereof The Government of the U. S.of America as Represented by The Sec. of Health and Human Svc. (US) 2004-07-08 US disclosed
EP-1417190-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgen Inc. (US) 2004-05-12 EP disclosed
US-6706729-B1 A METHOD FOR DISSOCIATING A METAL ION FROM A ZINC FINGER-CONTAINING PROTEIN; INHIBITING VIRUS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2004-03-16 US disclosed
US-6635771-B2 Useful as intermediates in the synthesis of compounds having activity as chemical inhibitors of various phospholipase enzymes, particularly phospholipase A2 WYETH 2003-10-21 US disclosed
US-20030166649-A1 Methods for treating arthritic disorders WYETH 2003-09-04 US disclosed
US-20030158405-A1 Chemical intermediates for making a phospholipase enzyme inhibitors WYETH 2003-08-21 US disclosed
WO-2003064387-A2 SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS F. HOFFMAN-LA ROCHE AG (CH) 2003-08-07 WO disclosed
US-20030149029-A1 Methods for treating asthmatic conditions WYETH 2003-08-07 US disclosed
US-20030144282-A1 Inhibitors of cytosolic phospholipase A2 WYETH 2003-07-31 US disclosed
WO-2003009850-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC. (US) 2003-02-06 WO disclosed
EP-1087941-A2 THIOLESTERS AND USES THEREOF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) 2001-04-04 EP disclosed
WO-1999065871-A2 THIOLESTERS AND USES THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-23 WO disclosed